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IN a review devoted to the discussion of colchicine as a possible chemothera-
peutic agent for cancer (Ludford, 1945), attention was directed to the dual action
of this drug on tumours. It is the most potent of mitotic poisons, and as. the
action of these substances is greatest where cell division is most frequent, col-
chicine has a relatively greater effect upon rapidly growing neoplasms than upon
most tissues of adult organisms. Furthermore, since endothelial cels ofgrowing
capillaries are particularly sensitive to its toxic action, it induces extensive
haemorrhage in the soft highly cellular rapidly growing types of tumours.
Evidence was adduced that regression ofmalignant growth produced by colchicine
is mainly the result of this vascular damage. Considerable variation in the
response of different tumours to treatment with this drug has been reported,
and the present paper represents an attempt to elucidate the factors which are
responsible for such differences.
The "colchicinic effect."
An experiment with a carcino-sarcoma of Strong A mice will serve to demon-
strate the typical reaction to colchicine of a soft, highly cellular and rapidly
growing tumour in a strain of mice the growing capillaries of which are highly
sensitive to its toxic action. Some account of this carcino-sarcoma has already
been given in a previous paper (Ludford and Barlow, 1945). At the time the
experiment to be described was performed, sections exhibited large compact
groups ofcarcinoma cells, surrounded by an abundant and highly cellular stroma,
composed of enlarged and hyperchromatinic spindle-shaped and polymorphic
cells, presenting the typical cytological appearance ofsarcoma cells. This tumour
was transplanted by subcutaneous grafting into the right axillae of ten young
adult Strong A mice. Seven days later colchicine was injected subcutaneously
into 5 mice. An aqueous solution was employed in a concentration of 1 part in
10,000 of distilled water. This had been prepared six days previously, when it
was maintained at the temperature of boiling water for ten minutes to reduce the
possibility ofinfection, and was stored in the dark for use throughout the exp6ri-
ment. Since the activity of colchicine is reduced by high temperatures and by
keeping, especially when exposed to light, the solution employed for this experi-
ment was rather less potent than a freshly prepared solution. On the seventh
day injections were made as follows:
1st injection . 0@1 c.c. dorsally.
2nd ,, . 0*2 c.c. ventrally-30 min. later.
3rd ,, . 0 3 c.c. dorsally-21 hr. later.
4th ,, . 0* 1 c.c. ventrally-1 hr. later.
Altogether 0 7 c.c. of fluid containing 0 07 mg. of the alkaloid over a period of
four hours.R. J. LUDFORD
The following day all the mice so treated were ill. They were kept covered
with cotton-wool at room temperature. With one exception all recovered. The
very definite effect which this treatment had upon the subsequent growth of the
tumours is seen in Fig. 1 by comparing the size of the tumours of the controls
and the treated mice on the 21st day.
Control Treated
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01 234
FIG. 1.-Action of colchicine upon a carcino-sarcoma (D) in Strong A strain mice. Figures
indicate days after transplantation, arrows denote treatment, and crosses death of mice in
all figures. In this experiment one mouse only was treated on the 35th day.
By the 26th day the four surviving treated mice had recovered and were
re-injected as follows:
1st injection . 0 1 c.c. dorsally.
2nd ,, . 0*2 c.c. ventrally-45 min. later.
3rd ,, . 02 c.c. dorsally-2 hr. later.
4th ,, . 01 c.c. ventrally-2 hr. later.
Altogether 0,6 c.c. of fluid containing 0,06 mg. of the alkaloid, over a period of
4I hours.
Again the mice suffered from the toxic action of the drug, but survived.
When the tumours were charted four days later, on the 30th day, the difference
between those of the treated and control mice was considerable (Fig. 1). The
tumour of one of the treated mice seemed to have regressed completely. No
nodule was perceptible on palpation. However, as shown in the chart, all the
tumours subsequently recurred and grew progressively. One mouse received a
third series ofinjections on the 35th day as follows:
1st injection . 0
-4 c.c. dorsally.
2nd ,, . 0 2 c.c. ventrally 4 hr. later.
3rd ,, . 0 1 c.c. dorsally-2 hr. later.
Nevertheless malignant growth was progressive.
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It will be observed from the chart (Fig. 1) that by the 50th day after trans-
plantation the tumours ofthe treated mice had attained approximately the same
size as the controls reached on the 30th day.
In other experiments with the same tumour there has been occasionally
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FIG. 2.-Regression of a sarcoma (C) in Strong A strain mice after treatment with colchicine.
after the shortest possible interval consistent with survival of the mice. Such
treatment is invariably accompanied by a high mortality.
An experiment with a spindle-celled sarcoma in Strong A mice demonstrates
the possibility of completely inhibiting malignant growth. This sarcoma was
one which originated by the sarcomatous transformation of the stroma of a
mammary carcinoma. Mice into which it is transplanted do not usually survive
long, as it rapidly penetrates the skin and leads to considerable superficial ulcera-
tion. Of six young adults transplanted with this sarcoma three were treated
7, 11 and 20 days after transplantation. On each occasion they received a single
injection of 0-048 mg. of colchicine. This was freshly prepared for the first
injection, 8,0 mg. ofthe drug being dissolved in 50 c.c. ofdistilled water and kept
in boiling water for 4 minutes. The chart (Fig. 2) shows that two of the treated
tumours regressed completely and the mice recovered.. On the 74th day after
transplantation they were killed and examined for traces of sarcoma tissue.
None was found.
It should be emphasized that complete inhibition of malignant growth by
colchicine is exceptional. What may be considered the typical " colchicinic
effect " is regression of growth followed by recurrence. The magnitude of the
effect induced by the same dose ofthe drug varies very considerably with different
tumours, and also with the same type of tumour in different, strains of mice.
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The factors which have been found to determine the extent of the "colchicinic
effect " may be classified as follows:
ri. Age.
Host factors . 2. Genetic constitution.
3. Cumulative toxic action.
.Rate of growth.
Tumour factors 5. Histological structure.
6. Acquirement of tolerance.
Factors influencing the " colchicinic effect."
1. Age.-Since activelygrowing tissues are most sensitive to mitotic poisoning,
it is to be expected that young animals would be more susceptible than older ones
to the toxic action of the drug. Ries (1939) reported that a 42-days-old mouse
will survive more than 17 times the dose of colchicine which is lethal to one
10 days old.
The maximum inhibition ofmalignant growth occurs with the highest tolerated
doses ofthe drug. Therefore, to obtain the greatest arrest oftumour growth it is
necessary to employ animals at the age when they are most resistant to the
general toxic action and the largest doses can be administered. The best results
have been obtained with young adult mice. Old mice are less able to tolerate
the drug. Thus, 11 Strong A mice varying in age from 18 months to 2 years
and 12 young adults were each injected with 0,056 mg. of colchicine. Within
3 days five of the old mice died and the remainder were almost moribund, but all
the young adults survived.
2. Genetic constitution.-Experiments have been carried out with tumour-
bearing mice of four inbred strains and various hybrids. The mice of the inbred
strains fall into three groups according to their sensitivity to the toxic action
of the drug, thus:
Group 1 . . R III.
2 . . C3H.
3 . . Strong A and C 57.
The largest single doses which it has been found practicable to employ in the
treatment of similar types of tumours in these strains are in the ratio of 5:4:3.
But while R III mice will tolerate doses which would be lethal to A or C 57 mice,
a quantity of the drug which induces considerable regression of growth in an A
mammary carcinoma has a negligible effect on a mammary carcinoma growing
at the same rate in R III mice. Furthermore, the extent of the haemorrhage
induced in the same tumour growing in mice of different strains varies, although
the mice may be equally sensitive to the toxic action of the drug. Mice of the
A and C 57 strains employed tolerated the same single large doses of the drug,
although the A mice survived repeated doses rather better. It has been observed
that when tumours ofa similar histological type and rate ofgrowth (both sarcomas
and carcinomas) in these strains of mice are treated with the same doses of col-
chicine, the tumours of the A mice become more haemorrhagic and regress more
than those ofthe C 57 strain. A transplantable spindle-celled sarcoma originally
induced by Dr. Dmochowski in C 57 mice by methyl-cholanthrene has been
transplanted into both C 57 and A strain mice. A single injection of 0'048 mg.
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of colchicine induced greater regression of tumour growth in the A strain. The
difference in the reaction of another tumour growing in these two strains is
demonstrated by the following experiment:
Sarcoma 37 S which has been transplanted for many years in mixed hybrid
micewas transplanted into mice ofthe A andC 57 strains. Miceofapproximately
the, same weight were selected for this experiment. One half of those of each
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FiG. 3.-Action of colchicine upon sarcoma 37 grown in Strong A and C 57 strain mice.
Tumours in C 57 mice indicated by outline, tumours in A mice stippled. Tumourregression
is greatest in the A mice.
13th days after transplantation. At each injection each mouse received sub-
cutaneously on the back 0032 mg. of colchicine in 02 c.c. of distilled water.
Fig. 3 records the size of the sarcomas when charted on the 6th, 13th and 18th
days after transplantation. The size ofthe tumours in the C 57 mice is indicated
in outline, and in the A mice by the stippled areas. It will be observed that
there islittle difference inthe size ofthe tumours inthe control animals. Actually
growth is slightly more rapid in the A mice, but there is a definite difference in
the two strains of treated mice. Tumour growth in A mice is inhibited more
than in C 57 mice. Twenty-four hours after the first injection one mouse ofeach
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strain of those treated (not included in the chart) was killed for examination of
the tumour. That in the A mouse exhibited considerably more haemorrhage.
Attention has been directed by several investigators to the similarity in the
action on tumours of colchicine and bacterial filtrates, and the relevant literature
was discussed in a recent review (Ludford, 1945). It is of interest to recall that
Andervont (1936) demonstrated differences in the susceptibility to B. coli filtrates
ofsarcoma 37 whengrown in different inbred strains ofmice, and also " in different
lots of stock mice " obtained from dealers.
3. Cumulative toxic effect.-It is impossible to administer repeatedly large
doses of the drug to animals owing to its cumulative toxic effect. After several
injections at short intervals within the dosage range necessary to induce tumour
regression, mice lose weight and become almost completely depleted offat tissue.
Attempts have been made to find an antidote to colchicine poisoning, but without
success; saline and glucose solutions, tissue extracts, atropine, adrenaline,
desoxycorticosterone acetate and thiol compounds have been injected into mice
suffering from colchicine poisoning, but without beneficial results.
4. Rate of tumour growth.-Tumours of various types in different inbred
strains of mice have been transplanted for comparative study. The magnitude
of the " colchicinic effect " with tumours of any one inbred strain is, in general,
proportional to their rate of growth. Below is summarized the result of experi-
ments with mice offour inbred strains. The dosage ofcolchicine is that adminis-
tered to young adults ofeach strain. The figures in brackets, after each tumour,
indicate the approximate rate ofgrowth in comparison with that ofthe A carcino-
sarcoma (Fig. 1). The tumours of each strain are arranged according to the
extent to which they undergo regression following treatment. Thus it will be
seen that the action of colchicine upon slow-growing tumours is negligible.
Extent of TABLE I.
"colchicinic Inbred strain:- A C 57 C3H R III
effect." Dosage:- 0048 mg. 0048 mgo.. 0(064 mg. 0-08 mg.
++ + . Carcino- .. .. Mammary
sarcoma D (1) carcinomas
D and E (1).
Sarcoma C (1)








B and C (2/5)
+ .. Squamous-cell ..
carcinoma (2/3)
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5. Histological structure.-Two tumours in Table I (the C 57 squamous-celled
carcinoma and the R III fibro-sarcoma) responded less to the drug than would
have been anticipated onthe basis oftheirrate ofgrowth. Both were characterized
by their relatively firm consistency. It seems probable that in tumours of this
type the blood capillaries are not so readily disrupted. This aspect ofthe problem,
however, requires further investigation. The application of the transparent-
chamber technique devised by Algire (1943) might reasonably be expected to
extend our knowledge of the action of drugs upon different types of tumour
capillary systems.
6. Acquirement of tolerance.-After tumour-bearing mice have received several
large doses of colchicine fiurther treatment is less successful in bringing about
tumour regression. This is illustrated by the growth of the carcinoma in the
sixth of the treated mice in the experiment described below (Fig. 4). A similar
acquirement of tolerance by tumours to the haemorrhage-inducing action of
bacterial polysaccharides has been reported by Shear (1944).
Application of the preceding resultsfor obtaining the maximum " colchicinic effect."
Discrepancies in the reports on the action of colchicine on neoplasms which
have been published are explicable on the basis ofthe preceding findings. Further-
more, they indicate the experimental conditions under which the maximal effect
on tumour growth is most likely to be obtained. The following experiment
was planned so as to establish the most favourable conditions for obtaining
tumour regression.
Carcinoma 63 was selected as being a soft, highly cellular tumour with large
numbers of mitotic figures. It was transplanted into R III mice because of the
strains available they toleratethelargest doses ofthedrug, andtheirnewly-formed
capillaries undergo considerable destruction following the administration of large
doses. Therefore, by this procedure the carcinoma cells were subjected to the
highest possible concentration compatible with survival of the mice, so that the
maximum direct toxic action on the malignant cells was combined w.th extensive
vascular damage. Further, since the carcinoma cells were not homozygous with
the cells of the mice into which they were transplanted, an additional factor
favouring the experimental inhibition of tumour growth was introduced.
In assessing the significance ofthe results of any experiments ofthis kind it is
necessary to take into account the results ofgrafting carcinoma 63 in R III mice.
These have been as follows:
227 mice of the R III strain transplanted with carcinoma 63.
192-tumours grew progressively . . . 84*6 per cent
15-no growth . . . . . . 6*6
4-regressed within two weeks . . 1 8
16-regressed after two weeks . . . 7*0
In Fig. 4 is recorded by weekly chartings the growth of carcinoma 63 in the
control and treated mice. In the case of the eight controls only five chartings
are included. The figures at the top of the diagram give the number of days
after transplantation when the tumours were recorded. It will be observed
that all but one grew progressively. One mouse was killed on the 21st day,
6
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and its tumour was grown in tissue cultures in order to test its growth rate in
vitro. It was found to Be normal for this carcinoma. The experimental mice
were treated on the 14th day after transplantation with a 1 in 10,000 solution
Treated
e _ _ _ -_ _ e _ __.
# * + O~~~~~~~ 1 2 3 4 5
FIG. 4. Action of colchicine upon carcinoma 63 grown in R III strain mice, which tolerate the
- largest doses of the alkaloid.
Of colchicine in distilled water which had been maintained at the temperature
of boiling water for ten minutes. The treatment was as follows:
1st injection . 04 c.c. dorsally.
2nd ,, . 0 3 c.c. ventrally-3 hours later.
3rd ,, . 0 2 c.c. dorsally-2 hours later.
Altogether 0 9 c.c. offluid containing 0 09 mg. of colchicine
over a period of five hours.
As is usual with such large doses the mice suffered severely. Three succumbed,
one each on the 15th, 16th and 18th days. Ofthe survivors, the tumours-oftwo
7114 -121 1[28 35 1 7-.I 14 121 28 1 3
. f* Control
p.,. RR ***-
|' fGrowthtested , *
3 in vitro Enteritis
7 14 -I21 8 1.5 142 1 9 156 1 6.3 7
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regressed completely, and the remainder were treated again on the 29th day
as follows:
1st injection . 0 3 c.c. dorsally.
2nd ,, . 0*3 c.c. ventrally-21 hours later.
3rd ,, . 0 '2 c.c. dorsally-2 hours later.
Altogether 0*8 c.c. of fluid containing 008 mg. of
colchicine over a period of 4- hours.
Two other tumours regressed completely, but the-,remaining two continued
to grow progressively. Both received the same treatment on the 37th day.
One died with a large tumour on the 45th day. The other received two sub-
sequent treatments to which it failed to respond. The five mice which had been
completely " cured " were kept under observation for a year and were then
killed. Post-mortem examination revealed no trace of carcinomas.
The charting of all the tumours in these experiments was carried out inde-
pendently by Mr. A. Chapman, the Senior Technician in charge of this work.
DISCUSSTON9
With all the tumours which underwent regression in the preceding experiments
there was extensive haemorrhage following treatment. This'was most readily
induced in the A strain mice. A few hours after the injection of the maximum
sub-lethal doses of the drug the tumours appeared blue through the skin. Sub-
sequently superficial ulceration was of common occurrence.
Since Boyland and Boyland (1937) first drew attention to the similarity of
action of colchicine and bacterial filtrates they have been shown to behave alike
in most other respects. With both, complete regression of some transplantable
and spontaneous tumours has been effected.' The results acquire significance in
that they indicate the limitation ofhaemorrhage-inducing agents in the treatment
of malignant growths.
That some form of damage to the capillary system of tumours might be'the
best way to inhibit malignant growth was suggested by Woglom (1922). A
critical review of the evidence concerning tumour regression led him to raise the
question whether " the receding tumor may not differ from the growing one
only in the extent to which its blood vessels have been obliterated bythrombosis."
He pointed out that the blood vessels of many tumours are more subject to
thrombosis than those ofnormal tissues, and he conceived the possibility of both
chemical and mechanical factors being responsible. The former resulted from
the abnormal metabolism of malignant cells, and the latter was described as
" the mechanical pressure which the rapidly increasing parenchyma must often
exert upon its vessels, with all the possibilities of injury to their walls which
this would entail."
More recently Algire (1945) has devised an adaptation of the transparent
chamber technique which enables microscopic observations to be made of the
development of the blood vessels of tumour transplants. He reports that
although many vessels in growing tumours become very large, " differentiation
into arterioles and venules was not evident." In mammary cancers he observed
the development of "blood-filled cul-de-sacs." "These appeared to result from
6§
83R. J. LUDFORD
occlusioni of the tumour capillaries by pressure of the growing cells.' It was
suggested that rupture of these " cul-de-sacs " was responsible for the haemor-
rhagic character of mammary carcinomnas.
Mechanical pressure of tumour parenchyma upon capillaries was also cited
b)v Mottranm (1928) as the cause of vascular obstruction in tumours following
irradiation. He pointed out, and the writer confirmed (Ludford, 1932), that
nalignant cells which had been irradiated may undergo considerable hypertrophy
(liring the period of mitotic arrest. This enlargement of the malignant cells by
imeposing pressure upon the sinusoidal-like capillaries was considered to rIesliit
in their obliteration, and in stagnation thrombosis.
A similar mechanical process might contribute to the vascular (lamage caulsed
i)v bacteria] filtrates and colchicine. Apitz (1933) first reported that can1cel
cells acquired an oedematous appearance after treatment with bacterial filtrate.
aind Andervont (1936) remarked that " careful examination reveals swelling of
some tumnor cells prior to the hemorrhage, indicating that the bacterial pro(lllcts
may hiave some direct effect upon the tumor cell." He observed that tlhe bloo(1
vessels became dilatedl before rupturing. Gerber an(d Bernheimi (1938) as the
result of their histological studies came, however, to the conclusioni that the?
effect offiltrate on tumours was the result of a direct action uipon flalignanit cells
rather than upon the capillaries.
The direct action of colchicine upon cell division needs no reiteration. It is,
lhow-ever, pertinent to pointout in this connection that the cells arreste(l in mnitosis
become considerably swollen, so that Barber and Callan (1943) describedl their
condition as a state of " intracellular dropsy." As very large nuimbers of cells
of rapidlyv growing tumours exhibit this condition after treatment with the
allaloid, increased pressure of the tumour parenchyma upon the capillaries
would( appear inevitable. This, and to a much greater extent the toxic actionI
of the drug upoIn newly formed capillaries, would seem to contribute towar1ds a
reasonable, if not complete, explanation of the haemorrhage-induicing action of
colchicine.
While emphasizing the major role of haemorrhage in bringing about tumnlour
regression, the possibility of a direct toxic action of the alkaloid on tumours has
not been ignored. Experimental work with a wide range of animal ttumours
(lemionstrates that there is considerable variation in the sensitivity of malignant
cells to toxic substances both in vivo and in vitro. There would also seeni to be
(ifferences in the sensitivity of cells of the same tumour to mitotic poisons, as
it is not uncommon in tissue cultures of tumours treated with colchicine, and in
the tumours of animals which have been injected with the drug, to find amongst
numerous arrested metaphases a few cells which appear to be completing mitosis
in the normal manner. It is most unwise, to generalize about tumours fromn
experiments with a few selected types, and the possibility should not be over-
looked that with some new growths the direct toxic action on the nmalignant
cells may play a much greater part in bringing about tumour regression. This
might be expected to be the case with lymphomas and lymphosarcomas, since
thymocytes and lymphocytes are usually the first cells to exhibit injury when
toxic substances are injected into animals (Dustin, 1934). WVith the tuimouirs
used in the present investigation, however, the intratumoral hlaemorrhage
was so extensive as to render it unlikely that the direct toxic action on the canlcer
cells was a significant factor in contributing to the retrogressive process.
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In discussing the significance ofhaemorrhage upon tumour gr'owth Anlder'vonlt
anid Shimkin (1939) wrote: " Our experience has indicated repeatedly that the
regression of transplanted tumors after bacterial filtrate treatment is present
only when a gross hemorrhage is produced in the tumor, and that regression
is directly proportional to the amount of hemorrhage. Thus, if only the central
portion of the tumor becomes hemorrhagic only that area regresses, while the
growth of the non-hemorrhagic periphery is uninterrupted." Exactly the same
statement would apply to colchicine treatment.
SUMMARY.
1. Treatment of soft, highly-cellular, rapidly growing mouse tumours with
colichicine, in dosages just below the lethal dose induces haemorrhage, which
results in tumour regression. Typically there follows recurrence of growth
(Fig. 1), but occasionally complete regression is obtained (Fig. 2 and 4).
2. Factors which influence the " colchicinic effect " are:
A. Host factors.
(i) Age.-Young adults tolerate the biggest doses and enable tlle
greatest regression of tumour growth to be effected.
(ii) Genetic constitution.-This determines (a) the maxinium dosage
tolerated, and (b) thesensitivity ofthe tumourcapillaries to the destruc-
tive action of the drug (Fig. 3).
(iii) Cumulative toxic action.-This limits the repeated application
of the drug at short intervals.
B. Tumour factors.
(i) Rate of growth.-The degree of response to treatment is, in
general, proportional to the rate of tumour growth in any one inibred
strain (Table I).
(ii) Histological structure.-Tumours which respond bost to treat-
Iment are the soft, highly-cellular type.
(iii) Acquirement of tolerance.-After several large doses tuItnours
respond less to treatment (Fig. 4).
3. Attention is directed to the similarity in the action of bacterial filtrates
and colchicine upon tumour growth. With both, tumour regression is plrimarily
the result of haemorrhage, and the degree of regression is dependenit upon the
extent of the haemorrhage.
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